Extrapyramidal adverse drug reactions associated with trimetazidine: A series of 21 cases

Fundamental and Clinical Pharmacology

Volumn 26, Issue 2, 2012, Pages 198-203

  Masmoudi, Kamel ^a   Masson, Henri ^a,b   Gras, Valérie ^a,b   Andréjak, Michel ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Drug induced side effects; Extrapyramidal disorders; Parkinsonism; Trimetazidine

Indexed keywords

CARBIDOPA; CINNARIZINE; DOPAMINE 2 RECEPTOR; FLUNARIZINE; LEVODOPA; PIPERAZINE; TRIMETAZIDINE;

ADULT; AGED; AKINESIA; ARTICLE; BUCCOLINGUOFACIAL DYSKINESIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG SAFETY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYNDROME; FEMALE; GAIT DISORDER; GERIATRIC PATIENT; HEARING IMPAIRMENT; HUMAN; IDIOPATHIC PARKINSON DISEASE; INSOMNIA; MALE; ORTHOSTATIC TREMOR; PARKINSON DISEASE; PERIODIC LIMB MOVEMENT DISORDER; POSTURAL TREMOR; PRESCRIPTION; PRIORITY JOURNAL; REST TREMOR; RESTLESS LEGS SYNDROME; RETINA MACULA AGE RELATED DEGENERATION; RIGIDITY; RISK BENEFIT ANALYSIS; SIDE EFFECT; TINNITUS; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR; VOLITIONAL DYSKINESIA;

AGED; AGED, 80 AND OVER; AKATHISIA, DRUG-INDUCED; BASAL GANGLIA DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 84858070163     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01008.x     Document Type: Article

References (11)

1. Jiménez-Jiménez F.J., Garcia-Ruiz P.D., Molina J.A. Drug-induced movement disorders. Drug Saf. (1997) 16 180-204.
2. Bondon-Guitton E., Perez-Lioret S., Bagheri H., Brefel C., Rascol O., Montastruc J.L. Drug-induced parkinsonism: a review of 17years' experience in a regional pharmacovigilance center in France. Movement Disorders. Mov. Disord. (2011) 12 2226-2231, Doi: [Epub ahead of print].
3. Masmoudi K., Gras-Champel V., Douadi Y., Masson H., Andrejak M. Trimetazidine-a new aetiology for extrapyramidal disorders: a case of parkinsonism and akathisia. Therapie (2005) 60 603-605.
4. Marti-Masso J.F. Trimetazidine-induced parkinsonism. Neurologia (2004) 19 392-395.
5. Marti-Masso J.F., Carrera N., Poza J.J., Lopez de Munain A. Trimetazidine induces parkinsonism, gait disorders and tremor. Therapie (2005) 60 419-422.
6. Sommet A., Azaïs-Vuillemin C., Bagheri H., Rascol O., Montastruc J.L. Trimetazidine: a new cause for drug-induced parkinsonism? Mov. Disord. (2005) 20 1080-1081.
7. Afssaps commission Nationale de Pharmacovigilance 29/03/2011. [accessed 1 October 2011].
8. Sivet J., De la Gastine B., Mosquet B. et al. Trimetazidine-induced encephalopathy with choreiform disorders: a case report. Rev. Med. Int. (2008) 29 512-515.
9. Brücke T., Wolker C., Podreka I. et al. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects/A SPECT study. J. Cereb. Blood Flow Metab. (1995) 15 513-518.
10. Mena M.A., Yébenes J.G. Drug-induced parkinsonism. Expert Opin. Drug Saf. (2006) 5 759-771.
11. Thanvi B., Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgr. Med. J. (2009) 85 322-326.